Edwards Capital Stock from 2010 to 2025

EW Stock

USD 70.46 0.49 0.69%

Edwards Lifesciences Capital Stock yearly trend continues to be fairly stable with very little volatility. Capital Stock will likely drop to about 575.7 M in 2025. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

654.8 M

Current Value

575.7 M

Quarterly Volatility

210.1 M

Credit Downgrade

Yuan Drop

Covid

Check Edwards Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 92.8 M, Interest Expense of 11 M or Selling General Administrative of 1.9 B, as well as many indicators such as Price To Sales Ratio of 4.44, Dividend Yield of 0.0 or PTB Ratio of 4.78. Edwards financial statements analysis is a perfect complement when working with Edwards Lifesciences Valuation or Volatility modules.

Check out the analysis of Edwards Lifesciences Correlation against competitors.

Latest Edwards Lifesciences' Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Edwards Lifesciences Corp over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Edwards Lifesciences' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Edwards Lifesciences' overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Edwards Capital Stock Regression Statistics

	Arithmetic Mean	372,535,089
	Geometric Mean	322,917,185
	Coefficient Of Variation	56.39
	Mean Deviation	196,306,362
	Median	215,200,000
	Standard Deviation	210,082,636
	Sample Variance	44134.7T
	Range	439.6M
	R-Value	0.83
	Mean Square Error	14744T
	R-Squared	0.69
	Significance	0.00007
	Slope	36,606,208
	Total Sum of Squares	662020.7T

Edwards Capital Stock History

	2025	575.7 M
	2024	654.8 M
	2023	650.5 M
	2022	646.3 M
	2021	642 M
	2020	636.4 M
	2019	218.1 M

Other Fundumenentals of Edwards Lifesciences Corp

Issuance Of Capital Stock

Edwards Lifesciences Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Net Receivables	Good Will	Total Liab	Total Current Assets	Net Debt	Accounts Payable	Long Term Debt	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Treasury Stock	Short Term Investments	Net Tangible Assets	Capital Surpluse	Long Term Investments	Long Term Debt Total	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.96	0.69	0.92	0.89	0.97	-0.85	0.66	0.32	-0.61	0.82	0.89	0.96	-0.21	-0.65	0.7	0.96	0.8	0.48	0.53	0.33	-0.02	0.85	0.86	0.82
Total Stockholder Equity	0.99		0.98	0.63	0.91	0.82	0.97	-0.89	0.65	0.25	-0.62	0.85	0.88	0.95	-0.3	-0.63	0.71	0.96	0.74	0.42	0.46	0.34	-0.01	0.88	0.88	0.82
Retained Earnings	0.96	0.98		0.58	0.83	0.75	0.96	-0.89	0.54	0.26	-0.52	0.81	0.86	0.91	-0.3	-0.68	0.74	0.92	0.7	0.34	0.49	0.41	-0.05	0.88	0.86	0.8
Net Receivables	0.69	0.63	0.58		0.61	0.77	0.58	-0.36	0.76	0.44	-0.57	0.28	0.77	0.79	0.36	-0.64	0.25	0.76	0.94	0.63	0.52	-0.03	-0.2	0.69	0.71	0.75
Good Will	0.92	0.91	0.83	0.61		0.84	0.86	-0.76	0.77	0.24	-0.76	0.89	0.79	0.88	-0.36	-0.4	0.48	0.87	0.73	0.44	0.38	0.23	0.0	0.75	0.79	0.72
Total Liab	0.89	0.82	0.75	0.77	0.84		0.84	-0.61	0.63	0.5	-0.5	0.6	0.82	0.87	0.11	-0.63	0.56	0.85	0.87	0.64	0.68	0.25	-0.03	0.64	0.67	0.7
Total Current Assets	0.97	0.97	0.96	0.58	0.86	0.84		-0.92	0.5	0.29	-0.49	0.83	0.81	0.89	-0.24	-0.62	0.79	0.9	0.72	0.32	0.54	0.4	0.05	0.83	0.85	0.72
Net Debt	-0.85	-0.89	-0.89	-0.36	-0.76	-0.61	-0.92		-0.36	-0.09	0.42	-0.86	-0.63	-0.74	0.44	0.44	-0.71	-0.74	-0.5	-0.05	-0.35	-0.45	-0.2	-0.78	-0.83	-0.57
Accounts Payable	0.66	0.65	0.54	0.76	0.77	0.63	0.5	-0.36		0.24	-0.86	0.5	0.76	0.77	-0.13	-0.4	0.04	0.76	0.74	0.64	0.22	-0.04	0.01	0.67	0.69	0.79
Long Term Debt	0.32	0.25	0.26	0.44	0.24	0.5	0.29	-0.09	0.24		-0.11	0.05	0.33	0.32	0.22	-0.7	0.25	0.35	0.6	0.42	0.93	0.39	-0.03	0.21	0.23	0.24
Short Term Debt	-0.61	-0.62	-0.52	-0.57	-0.76	-0.5	-0.49	0.42	-0.86	-0.11		-0.55	-0.63	-0.71	0.26	0.24	-0.07	-0.69	-0.58	-0.45	-0.11	0.22	-0.01	-0.56	-0.62	-0.66
Intangible Assets	0.82	0.85	0.81	0.28	0.89	0.6	0.83	-0.86	0.5	0.05	-0.55		0.59	0.7	-0.66	-0.23	0.58	0.7	0.44	0.09	0.21	0.4	0.03	0.73	0.75	0.53
Common Stock	0.89	0.88	0.86	0.77	0.79	0.82	0.81	-0.63	0.76	0.33	-0.63	0.59		0.96	-0.05	-0.76	0.49	0.95	0.79	0.67	0.48	0.19	-0.04	0.8	0.77	0.97
Property Plant Equipment	0.96	0.95	0.91	0.79	0.88	0.87	0.89	-0.74	0.77	0.32	-0.71	0.7	0.96		-0.11	-0.7	0.57	0.99	0.84	0.61	0.5	0.2	-0.04	0.85	0.84	0.91
Current Deferred Revenue	-0.21	-0.3	-0.3	0.36	-0.36	0.11	-0.24	0.44	-0.13	0.22	0.26	-0.66	-0.05	-0.11		-0.21	-0.18	-0.13	0.17	0.29	0.24	-0.28	-0.13	-0.29	-0.28	-0.08
Treasury Stock	-0.65	-0.63	-0.68	-0.64	-0.4	-0.63	-0.62	0.44	-0.4	-0.7	0.24	-0.23	-0.76	-0.7	-0.21		-0.5	-0.73	-0.72	-0.59	-0.81	-0.43	0.03	-0.58	-0.53	-0.69
Short Term Investments	0.7	0.71	0.74	0.25	0.48	0.56	0.79	-0.71	0.04	0.25	-0.07	0.58	0.49	0.57	-0.18	-0.5		0.62	0.43	0.17	0.49	0.3	-0.08	0.61	0.56	0.42
Net Tangible Assets	0.96	0.96	0.92	0.76	0.87	0.85	0.9	-0.74	0.76	0.35	-0.69	0.7	0.95	0.99	-0.13	-0.73	0.62		0.84	0.62	0.52	0.22	-0.02	0.86	0.84	0.91
Capital Surpluse	0.8	0.74	0.7	0.94	0.73	0.87	0.72	-0.5	0.74	0.6	-0.58	0.44	0.79	0.84	0.17	-0.72	0.43	0.84		0.63	0.7	0.14	-0.17	0.76	0.77	0.74
Long Term Investments	0.48	0.42	0.34	0.63	0.44	0.64	0.32	-0.05	0.64	0.42	-0.45	0.09	0.67	0.61	0.29	-0.59	0.17	0.62	0.63		0.43	-0.02	-0.13	0.32	0.25	0.63
Long Term Debt Total	0.53	0.46	0.49	0.52	0.38	0.68	0.54	-0.35	0.22	0.93	-0.11	0.21	0.48	0.5	0.24	-0.81	0.49	0.52	0.7	0.43		0.48	0.0	0.36	0.38	0.35
Short Long Term Debt	0.33	0.34	0.41	-0.03	0.23	0.25	0.4	-0.45	-0.04	0.39	0.22	0.4	0.19	0.2	-0.28	-0.43	0.3	0.22	0.14	-0.02	0.48		0.09	0.22	0.21	0.07
Cash And Equivalents	-0.02	-0.01	-0.05	-0.2	0.0	-0.03	0.05	-0.2	0.01	-0.03	-0.01	0.03	-0.04	-0.04	-0.13	0.03	-0.08	-0.02	-0.17	-0.13	0.0	0.09		-0.11	0.01	-0.06
Net Invested Capital	0.85	0.88	0.88	0.69	0.75	0.64	0.83	-0.78	0.67	0.21	-0.56	0.73	0.8	0.85	-0.29	-0.58	0.61	0.86	0.76	0.32	0.36	0.22	-0.11		0.97	0.83
Net Working Capital	0.86	0.88	0.86	0.71	0.79	0.67	0.85	-0.83	0.69	0.23	-0.62	0.75	0.77	0.84	-0.28	-0.53	0.56	0.84	0.77	0.25	0.38	0.21	0.01	0.97		0.78
Capital Stock	0.82	0.82	0.8	0.75	0.72	0.7	0.72	-0.57	0.79	0.24	-0.66	0.53	0.97	0.91	-0.08	-0.69	0.42	0.91	0.74	0.63	0.35	0.07	-0.06	0.83	0.78

Click cells to compare fundamentals

About Edwards Lifesciences Financial Statements

Edwards Lifesciences investors use historical fundamental indicators, such as Edwards Lifesciences' Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Edwards Lifesciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Capital Stock	654.8 M	575.7 M
Issuance Of Capital Stock	184.6 M	169.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Edwards Capital Stock from 2010 to 2025

Latest Edwards Lifesciences' Capital Stock Growth Pattern

Edwards Capital Stock Regression Statistics

Edwards Capital Stock History

Other Fundumenentals of Edwards Lifesciences Corp

Edwards Lifesciences Capital Stock component correlations

About Edwards Lifesciences Financial Statements

Also Currently Popular

Additional Tools for Edwards Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY